Skip to main content
OpenTrials
Completed

NCT Number: NCT06941597

Comparison of Two Gait Re-training Modalities During a Cardiac Rehabilitation Stay: Benefit of Orienteering Walking

Cardiovascular disease (CVD) is the leading cause of death in France for women and the second leading cause of death for men after cancer. They cause around 140,000 deaths every year, or almost 400 people every day throughout France. CVD also accounts for over a million hospital admissions a year, 160,000 of which are attributable to heart failure.

At present, cardiovascular rehabilitation centres mainly use exercise training methods based on sessions on cycloergometers and active walking (walking on a track and/or treadmill). Convinced of the added value of Orienteering, we have included it in our routine treatment as part of our Cardiac Rehabilitation programme, in addition to sessions on cycloergometers and active walking since 2021. As there is little literature on the subject in our population of interest, the aim of this study is to provide evidence of the relevance of orienteering in the cardiac rehabilitation programme.

We hypothesise that orienteering induces a similar cardiac response, amount of physical activity and perception of symptoms compared with an active walking session, while providing greater enjoyment of the activity.

Completed

Looking for future studies?

Notify Me

Key information

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patients with stabilised heart disease, coronary artery disease, heart failure, post-operative stay after cardiac surgery, congenital heart disease, patients at high cardiovascular risk and obliterative arteritis of the lower limbs;
  • Who have been informed and do not object to the study;
  • Over 18 years of age;
  • Participating in a cardiac rehabilitation programme;
  • With a walking distance of less than 3,600 metres;
  • Able to understand and comply with the requirements of the protocol.

Exclusion criteria

  • Pregnant or breast-feeding women
  • Persons under guardianship or trusteeship

Treatment and study plan

Primary outcomes

  1. To compare the average heart rate between an active walking session and an orientation walking session during the cardiac rehabilitation stay.

    Time frame: once during the second and third week of cardiac rehabilitation

    Average heart rate measured during the active walking session and the orienteering race.

Secondary outcomes

  1. To compare the intensity of effort between the active walking, orienteering and cycloergometer sessions.

    Time frame: once during the second and third week of cardiac rehabilitation

    The maximum heart rate (bpm) will be collected for each of the three sessions.

  2. To compare the intensity of effort between the active walking, orienteering and cycloergometer sessions.

    Time frame: once during the second and third week of cardiac rehabilitation

    The effort intensity score will be collected for each of the 3 sessions on a Borg scale (0-10). The modified Borg scale, also known as the CR10, is a simplified version of the original scale. It comprises 11 levels of perceived effort, ranging from 0 (no effort) to 10 (maximum effort).

  3. Compare the performance of the physical activity performed during the active walking versus orienteering session.

    Time frame: once during the second and third week of cardiac rehabilitation

    Physical activity performance will be measured for each session by the total number of steps taken during active walking and orienteering.

  4. Compare the performance of the physical activity performed during the active walking versus orienteering session.

    Time frame: once during the second and third week of cardiac rehabilitation

    Physical activity performance will be measured for each session by the time spent in the different intensity levels (light, moderate, vigorous) (in minutes and as a percentage).

  5. Compare the performance of the physical activity performed during the active walking versus orienteering session.

    Time frame: once during the second and third week of cardiac rehabilitation

    Physical activity performance will be measured for each session by the distance covered in kilometres.

  6. Compare the perception of effort between the active walking, orienteering and cycloergometer sessions.

    Time frame: once during the second and third week of cardiac rehabilitation

    Perceived motivation to carry out the activity using a Likert scale from 0 to 5. The Likert scale is a semantic scoring system, generally made up of 5 or 7 items, which is used in surveys to measure and evaluate perceptions, attitudes and opinions.

  7. Compare the sensation of pleasure between the active walking, orienteering and cycloergometer sessions.

    Time frame: once during the second and third week of cardiac rehabilitation

    The feeling of pleasure for the three activity sessions will be measured on a Likert scale from 0 to 5. The Likert scale is a semantic rating system, generally composed of 5 or 7 items, which is used in surveys to measure and evaluate perceptions, attitudes and opinions.

  8. To compare the desire to continue physical activity between the active walking, orienteering and cycloergometer sessions.

    Time frame: once during the second and third week of cardiac rehabilitation

    The desire to continue physical activity between the three physical activities will be measured by a Likert scale from 0 to 5. The Likert scale is a semantic rating system, generally composed of 5 or 7 items, which is used in surveys to measure and evaluate perceptions, attitudes and opinions.

  9. Compare the heart rate kinetics during the three sessions (orienteering, active walking and cycloergometer).

    Time frame: once during the second and third week of cardiac rehabilitation

    Changes in heart rate over the three sessions (recorded every 5 minutes for 50 minutes for each session)

Sponsors and collaborators

Lead sponsor

Fondation Ildys

Other

Collaborators

  • Univ Brest, Laboratory ORPHY, F-29200 Brest, France

Registry information

Acronym: CAMCO

Important dates

Study start
2025
Primary completion
2025
Study completion
2025
First posted
Apr 24, 2025
Registry last updated
Dec 24, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.